Potentiation of thiopentone sodium induced hypnosis by Berberis aristata in rodents

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue 1, 2012, Pages 131-133

  Dehar, Navdeep ^a   Walia, Rani ^a   Ratol, Sukhsagar ^a  

^a MAHARISHI MARKANDESHWAR INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Berberis aristata; Hypnosis; Mice; Thiopentone sodium

Indexed keywords

BERBERINE; DIAZEPAM; SODIUM CHLORIDE; THIOPENTAL;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BERBERIS ARISTATA; BODY MOVEMENT; CENTRAL NERVOUS SYSTEM; CLINICAL OBSERVATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HYPNOSIS; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SLEEP TIME;

EID: 84856791080     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kashmal (Berberis aristata): Fruitipedia: encyclopedia of edible fruits of the world. Available at: http://www.fruitipedia.com/kashmal.
2. Antimicrobial properties of berberine alkaloids in Coptis chinensis Franch by microcalorimetry. J Biochem Bio Phys Methods, 70(2008)845-849.
3. Kaneda Y, Torii M, Tanaka T: In Vitro effects of berberine sulfate on the growth of Entamoeba histolytica, Giardia lambia and Tricomonas vaginalis. Ann Trop Med Parasitol, 85 (1991) 417-425.
4. Xingshen Y, Yibin F, Yao T, Kwan-Ming N, SaiWah T, George KK, Chowing S, Yanbo Z, Jun T, Jiangang S, Seiichi K: Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J Ethno Pharmacol, 124 (2009) 130-136.
5. Anonymous: Wealth of India, Raw Materials, Publications and Information Directorate, SIR New Delhi, Vol.X (1976) 36.
6. Lahiri SC: Positive and negative inotropic effects of berberine on the cats' heart. Ann Biochem ExPer Med, 18 (1958) 95.
7. Lau CW, Yao XQ, Chen ZY, Ko WH, Haung Y: Cardiovascular actions of berberine. Cardiovasc Drug Rev, 19 (2001) 234-244.
8. Holy EW, Akhmedov A, Lüscher TF, Tanner FC: Berberine, a natural lipid lowering drug, exerts prothrombotic effects on vascular cells. J Mol Cell Cardiol, 46 (2009) 234-240.
9. Kim WS, Lee YS, Cha SH: Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J Physiol Endocrinol Metabol, 296 (2009) 812-819.
10. Kong W, Wei J, Abidi P: Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med, 10 (2009) 1344-1351.
11. Ivanovska N, Philipov S: Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immuno Pharmacol, 18 (1996) 553-561.
12. Sabir M and Bhide NK. Study of some pharmacological actions of berberine. Ind J Physiol & Pharmac, 15 (3) (1971) 111-132.
13. Shanbhag SM, Kulkarni HJ, Gaitonde BB. Pharmacological actions of berberine on the central nervous system. Jpn J Pharmacol, 20 (4) (1970) 482-487.
14. Kulkarni SK, Dhir A: Current investigational drugs for major depression. Exp Opi Invest Drugs, 18 (2009) 767-88.
15. Dhar J: Berberine and oriental sore. Ind J Dermatol Vernereol Lep, 46 (1980) 163.
16. Babbar OP, Chhatwal VK, Ray IB: Effect of berberine chloride eye drops on clinically positive trachoma patients. Ind J Med Res, 76 (1982) 83-88.
17. Mohan M, Pant CR, Angra SK: Berberine in trachoma. Ind J Opthalmol, 30 (1982) 69-75.
18. Marin-Neto JA, Maciel BC, Seeches AL, Gallo L: Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin Cardiol, 11 (1988) 253-260.
19. Yanxia N: Therapeutic effect of berberine on 60 patients with non-insulindependent diabetes mellitus and experimental research. Chinese J Integ Trad West Med, 1 (1995) 91-95
20. Yin J, Xing H, Ye J: Efficacy of berberine in patients with type 2 diabetes mellitus. Alt Med Rev, 57 (2008) 712-717.
21. Fujimori H: Potentiation of barbital hypnosis as an evaluation method for central nervous systems depressants. Psychopharmacologia, 7 (1965) 374.
22. Lynch JJ, Castagné V, Moser PC, Mittelstadt SW: Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies. doi:10.1016/j.vascn. 2011. 03. 003.
23. Vogel HG, Vogel WH: Drug Discovery and Evaluation, Pharmacological Assays. Springer-Verlag, Berlin Heidelberg, (1997) 267-269.
24. Kulkarni SK, Dhir A: On the mechanism of antidepressant-like action of berberine chloride, 28;589 (1-3) (2009) 163-72.
25. Janbaz, Gilani AH: Studies on preventive and curative effects of berberine on chemical induced hepatotoxicity in rodents. Fitoterapia, 71 (1) (2000) 25-33.
26. Singla D, Sharma A, Kaur J, Panwar B, Raghava GPS. BIAdb: A curated database of benzylisoquinoline alkaloids. BMC Pharmacology 2010, 10:4 Available at: http://www.biomedcentral.com/1471-2210/10/4A